Solid-supported phosphine ligands silica−SMAPs {[silica gel 60N]−SMAP ( 1a ) or [CARiACT Q-10]−SMAP ( 1b )}, which are composed of a caged, compact trialkylphosphine (SMAP) as a ligand and silica gel (silica gel 60N or CARiACT Q-10) as a support, were synthesized through surface functionalization. The supported phosphines ( 1a, b ) were structurally characterized by solid-state 13 C, 29 Si, and 31 P cross-polarization/magic angle spinning (CP/MAS) NMR spectroscopies and N 2 adsorption measurements. Complexation of 1a, b with [RhCl(cod)] 2 afforded a mono(phosphine)-rhodium complex Silica−SMAP−RhCl(cod) exclusively, even in the presence of excess ligands, as proved by solid-state 13 C and 31 P CP/MAS NMR spectroscopies and Rh K-edged X-ray absorption fine structure (XAFS) measurements. Heterogeneous catalysts that were prepared from [RhCl(C 2 H 4 ) 2 ] 2 and 1a, b showed exceptionally high catalytic activities for the reaction of sterically hindered ketones (including di- tert -butyl ketone) and triorganosilanes such as Et 3 SiH and ( t -Bu)Me 2 SiH. The catalyst from 1b showed no leaching of rhodium after reaction and was reusable without decrease of the activity.
No takes yet. Share an insight, caveat, or question.
Hamasaka et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: